CHEK2 and cancer: In particular, NGS analysis highlighted ten cancer-related genes (PARP2, FANCM, RAD51B, MLH3, DICER1, XRCC3, MAPK1, SMARCB1, CHEK2, and EP300), besides NF2, whose loss is still not clearly proven to be related to PM.